Dentsply Sirona heads into second-quarter earnings release amid a complex business recalibration, navigating both bright spots in product innovation and persistent macroeconomic pressures. A notable ...
Throughout the last three months, 5 analysts have evaluated Dentsply Sirona (NASDAQ:XRAY), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback